Development Plans

The Institute is located in the Hangzhou Medical Port Town, home to more than 1,000 famous biomedical enterprises at home and abroad. The Phase-I project with a land area of 80,000 ㎡ and a building area of 38,000 ㎡ has been completed and put into operation. The Phase-II project with a land area of around 53,300 ㎡ and a building area of 200,000 ㎡ will be designed as the Clinical Research Center and the Joint R&D Center to meet the needs of more than 1,000 researchers, doctors and entrepreneurs, essentially achieving an all-encompassing coverage of scientific research, technology transfer and industrial application.

Phase 1


Covers an area of 120 acres and a construction area of 35,000 square meters. The total equipment investment was 300 million yuan. Phase 1 serves as a base for a professional scientific research platform for material analysis and testing, cell characterization, etc. We will cooperate with the University of Chinese Academy of Sciences Cancer Hospital to realize the sharing of clinical resources, sample resources and information resources.

Phase 2

Under Construction

Covering a land area of 80 acres and a construction area of 150,000 to 200,000 square meters, Phase 2 will be home to a biological sample center, a tumor big data center, an experimental animal center, a result transfer center and other national public platforms and regional sharing centers to meet the requirements of more than 1,000 people and future development space.

Phase 3

Planning Stage

Covering an area of 600 acres, we will build a high-end scientific research and clinical platform of the Chinese Academy of Sciences in the field of tumor and basic medicine research and development, as well as support the construction of the affiliated Qiantang Hospital (a general hospital) and the tumor precision treatment center. It is planned to be put into use at the end of 2024 to fulfil the development of the whole chain of medical treatment, teaching and scientific research.